In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization

Nicolas L. Palaskas, Anita Deswal

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization'. Together they form a unique fingerprint.

Medicine & Life Sciences